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Abstract 
Fibroblast growth factor 2 (FGF-2) – an important paracrine growth factor – binds 
electrostatically with low micro-molar affinity to heparan sulphates present on extracellular 
matrix proteins. A single molecular analysis served as a basis to decipher the nanomechanical 
mechanism of the interaction between FGF-2 and the heparan sulphate surrogate – heparin – 
with a modular atomic force microscope (AFM) design combining magnetic actuators with force 
measurements at the low force regime (101 – 104 pN/s).  Unbinding events between FGF-2–
heparin complexes were specific and short-lived.  Binding between FGF-2 and heparin had 
strong slip bond characteristics as demonstrated by a decrease of life-time with tensile force on 
the complex. Unbinding forces between FGF-2 and heparin were further detailed at different pH 
as relevant for (patho-) physiological conditions. An acidic pH environment (5.5) modulated 
FGF-2 – heparin binding as demonstrated by enhanced rupture forces needed to release FGF-2 
from heparin-FGF-2 complex as compared to physiological conditions. This study provides a 
mechanistic and hypothesis driven model on how molecular forces may impact FGF-2 release 
and storage during tissue remodeling and repair.  
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Introduction 
The extracellular matrix (ECM) is composed of various structural and adhesive biomolecules, 
forming a dense 3 dimensional (3D) network in tissues and organs. Apart from being an 
anchorage scaffold for cells, the ECM plays a pivotal role in spatial and temporal coordination of 
growth factors (GF).1-2 One prominent example is fibroblast growth factor 2 (FGF-2, basic FGF), 
binding electrostatically in the low micro-molar range to negatively charged heparan sulphate 
(HS) polysaccharides 3 4 (Figure 1A). After cellular secretion, FGF-2 is stored in the ECM on 
HS of proteoglycans such perlecan5 and agrin6 as well as on basement membranes of connective 
tissue.7 It is for this mechanism that the activity of FGF-2 is linked to ECM remodeling, 
degradation and turnover.8 As potent mitogenic growth factor, FGF-2 is spatially and temporarily 
tightly regulated during embryonal development and in tissue repair9-10, showing proliferative 
effects on a large number of cell types derived from mesodermal and ectodermal origin, 
including  fibroblasts, mesenchymal stem cells and endothelial cells.11  
Cell stimulation requires the formation of a ternary complex composed of FGF-2, FGF-receptor, 
and HS co-receptor located on the cell surface.12 Therefore, the interaction of FGF-2 and heparin 
– a HS surrogate – has been extensively studied based on both energetic (isothermal titration 
calorimetry; ITC)3 and kinetic characterization (surface plasmon resonance; SPR).13 However, 
these methods do not allow investigations of FGF-2 – heparin complex interaction on the single-
molecule level as required for building the force landscape of this interaction. In tissues, the 
ECM is subject to physiological forces including shear stress of the interstitial fluid14 and at the 
same time to contraction forces exerted by surrounded cells.15 Fibroblastic cells undergo 
periodic, low force (~ 100 pN) subcellular contractions but with repetitive occurrence, which is 
increased at higher substrate stiffness or during differentiation.16-17  These findings suggest that 
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tissue forces and tissue deformations may be relevant for FGF-2’s ECM storage and release as 
well as for binding on cell surfaces. Apart from these physiological considerations, the 
interaction is also interesting in light of drug delivering matrices engineered from heparinized 
materials in tissue repair applications.18 Elucidating the underlying mechanism of the HS 
mediated interplay of GF with the ECM might provide new avenues for constructing advanced 
biomimetic scaffolds.  
Atomic force microscopy (AFM) has been successfully applied in various biomolecular 
measurements at single-molecule levels including receptor/ligand interactions and protein 
folding/unfolding experiments. We previously reported on a modular AFM design combining 
magnetic actuators for single-molecule force measurements.19  We integrated an electromagnet 
to a custom-built AFM head to enable direct magnetic actuation of cantilevers for better system 
dynamics. Furthermore, we employed this system to mechanically actuate functionalized 
micro/nano-particles against stationary cantilevers in a new mode of operation.20 Keeping the 
cantilever stationary and decreasing the size of the actuators drastically offered substantial 
advantages for stability, dynamics and resolution.   
In this study, we have performed biomolecular pulling as well as force clamp (single molecule 
constant force) AFM experiments using the method of microparticle-based magnetic actuators to 
probe the force landscape of heparin – FGF-2 interaction at the molecular level. We applied 
these methods to analyze unbinding forces and bond life-times between both interaction partners 
in a physiological state and at pathophysiological conditions, in which we mimicked a stressed 
cellular microenvironment by lowering the extracellular pH-value as result of hypoxia (low pO2 
levels) as found in wound sites, inflammation, or cancer.21-22   
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Results  
Probability of specific heparin – FGF-2 interactions probed with a magnetically actuated 
atomic force microscope  
Heparin and FGF-2 interactions were studied on a molecular level using a customized AFM 
setup, combining a piezo actuator together with an electromagnetic manipulation system.19 
Miniaturized magnetic, PEGylated (to reduce non-specific interactions) microparticles were used 
as secondary actuator for biomolecular force spectroscopy and force clamp experiments, as 
schematically represented in Figure 1B. We covalently immobilized low molecular weight 
heparin onto amine functionalized particles by NHS/EDC chemistry, whereas FGF-2 was 
physioadsorped onto the cantilever.  
At first, we aimed at analyzing the probability of specific unbinding events between both 
interaction partners in the described AFM system. The observed probability of bonding ruptures 
was 29.09 ± 3.11 % (Figure 2A). We optimized the concentration of the interacting molecules 
for probabilities of events at ~ 30 % to ensure that the majority of the recorded events are by 
virtue of single-molecular interactions.23  As controls the interaction between heparin decorated 
beads and FGF-2 was probed in the presence of a 10-fold excess of NaCl (impairing electrostatic 
interactions between both binding partners), and the probability of bonding was significantly 
reduced to 7.04 ± 4.2 %. Furthermore, saturation of the FGF-2 binding epitope with soluble 
heparin before the analysis resulted in a decrease to 1.96 ± 0.31 % of specific unbinding events, 
whereas non-specific interactions of FGF-2 with the unmodified magnetic particles were 1.53 ± 
0.63 % of all events analyzed. Thus, the binding of the FGF-2 modified AFM cantilever and 
heparin decorated microparticles is specific and occurs via the heparin binding site of FGF-2.  
Unbinding of heparin – FGF-2 under constant loading rates 
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A representative force curve with 70 pN/s loading rate and with a 50 pN unbinding force to 
liberate FGF-2 from the FGF-2– heparin complex is presented in Figure 2B.  The data points 
labeled with black circles (Figure 2C) represents the most probable unbinding forces collected 
for low loading rates using our magnetic actuation method. Additional sets of biomolecular force 
measurements were repeated using the piezo actuation capability of our AFM system (red stars, 
Figure 2C) and a commercially available AFM system (blue triangles, Figure 2C). Single force 
spectroscopy histograms of all tested methods at increasing order of loading rates are displayed 
in Figures S1–S3. The unbinding forces for individual loading rates were distributed around a 
single force level as displayed in Figures S1–S3, supporting the observation of single-molecular 
events.  All results using different methods and AFM systems were in a good agreement with 
each other as analyzed by linear regression (R2 values were 0.96 (low loading rate) and 0.91 
(high loading rate), respectively) (Figure 2C). Notably, we were able to decipher the heparin – 
FGF-2 interaction on a single molecule level using the magnetic actuators in our customized 
AFM setup at the low force regime (101 – 104 pN/s) in contrast to the commercial AFM or by 
piezo actuation of the same customized AFM system (Figure 2C). The method of magnetic 
particle actuation offered the required level of stability and resolution to probe the molecular 
interactions at low force regime, which is relevant in physiological conditions and at cellular 
force levels. The corresponding Bell’s parameters (koff and Δx) for the heparin-FGF-2 complex at 
low (101 – 106 pN/s) and high (106 – 107 pN/s) loading rates were calculated following the 
relationships (1) and (2) and are summarized in Table 1.  
The observation of continuous sequence of linear regimes suggested that there are two energy 
barriers along the reaction coordinate for the heparin-FGF-2 complex. The koff as determined for 
the low force regime was 0.62 s-1, whereas the koff value for the high loading rate regime was 
 7 
 
found to be ~ 4500-fold higher (Table 1). The dissociation constant (koff) for the heparin – FGF-2 
interaction has been determined building off SPR analysis (koff = 0.43 ± 1.92*10-2 s-1)13 and is in 
good agreement with our findings at the low force regime.  
The crystal structure of FGF-2 molecules indicates that the crystal lattice of a single molecule is 
approximately 3.5 nm x 3.5 nm x 3.5 nm (pdb file: 1BFB). The calculated values of Δx for both 
regimes (Table 1) are within the geometry of a single FGF-2 molecule. The shorter value of Δx 
for the second force regime reflected the Bell’s parameters for higher pulling rates. 
All following biomolecular pulling and force clamp experiments were thus conducted with the 
customized magnetic actuator AFM setup. In conclusion, we have used two different AFM 
setups and three different actuation methods - including the magnetic actuator - during the 
pulling experiments at constant loading rates. The results were complementary and agreed well 
with each other, suggesting that the binding of a heparin functionalized magnetic bead or a 
heparin modified substrate to the cantilever resulted from the interaction between heparin and 
FGF-2.  
Life-time analysis of single heparin – FGF-2 interactions  
As next we elucidated the bond life-time spectrum of single heparin – FGF-2 interactions. Our 
magnetic bead actuation methodology (Figure 1B) was used for force clamp experiments as 
previously described.20  We deployed various clamping forces, ranging from 19.6 pN to 172.7 
pN to study life-times between FGF-2 and heparin. A representative force clamp curve for 60 pN 
clamping force is shown in Figure 3A, resulting in an overall life-time of 600 ms of the FGF-2 
and heparin complex. We analyzed the life-time histograms for each clamping force. A 
representative life-time histogram together with the associated exponential density fit function 
for a clamping force of 39 pN with a mean value of the exponential fit function of 350 ms is 
 8 
 
shown in Figure 3C. All other life-time histograms in respect to the deployed clamping forces 
are given in Figure S4. We also calculated the cumulative probabilities for the clamping forces 
as shown in Figure 3B for three selected clamping forces, respectively. Inverse life-times and 
corresponding clamping forces were exponentially plotted (Figure 3D), and correlated to the 
unbinding rate at that specific clamping force. The unbinding rate increased at elevated clamping 
forces, suggesting that the complex between heparin and FGF-2 is subject to simple slip bond 
dissociation. This observation is in agreement with the data presented in Figure 2C where the 
strength of the unbinding force increased with the molecular loading rate.  As a result of these 
force clamp measurements, koff and Δx values were calculated using equation (1) resulting in 2.44 
s-1 and 0.02 nm, respectively.  
pH dependency of the  heparin – FGF-2 interaction 
Hypoxia in tissues acidifies the ECM down to pH 5 - 7.24 Providing that storage involves 
electrostatic interactions, local pH changes in the cellular microenvironment might contribute to 
alterations in GF release pattern. To investigate interactions between heparin and FGF-2 at three 
different pH-values (acidic: pH 5.5, physiological: pH 7.4, alkaline: pH 8.5) we first used 
conventional isothermal titration calorimetric measurements.3 Titration curves of low molecular 
heparin and FGF-2 are shown in Figure 4A-C.  Dissociation constants (KD), stochiometries (n) 
and changes in enthalpies (ΔH) were derived after non-linear fitting of the binding isotherms 
(Table 2). The binding of FGF-2 to heparin was enthalpically dominated and decreased linearly 
from -12.7 ± 0.5 (kcal/mol) to -15.4 ± 0.5 (kcal/mol), and to -20.2 ± 1.1 (kcal/mol) with 
elevating pH. The stochiometry remained constant at all tested pH-values with ~ three molecules 
of FGF-2 interacting with one molecule of heparin when FGF-2 was presented in excess. We 
were able to identify single KD values of ~ 200 nM for all tested pH values (Table 2). These are 
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in good agreement with previous measurements using low molecular weight heparin (3000 Da) 
and FGF-2 in HEPES buffered saline at pH 7.4.3  Although the binding enthalpy (ΔH) of FGF-2 
to heparin was reduced by approximately 18 % at acidic compared to physiological conditions, 
pH did not affect the equilibrium binding constant KD and, therefore, not the free enthalpy 
changes (ΔG) of binding between heparin and FGF-2. Notably, the entropic contributions (TΔS) 
of FGF-2 and heparin interaction decreased linearly from -3.8 ± 0.46 (kcal/mol) to -11.4 ± 1.1 
(kcal/mol) from acidic to alkaline conditions, respectively.  
We then switched to our magnetic actuated AFM-setup and performed biomolecular pulling 
measurements at the three different pH values as indicated above. We have collected force-
curves between heparin and FGF-2 at different loading rates (50 pN/s – 7000 pN/s), at pH 5.5, 
pH 7.4, and pH 8.5, respectively. All collected force spectroscopy histograms are provided in the 
SI (Figures S3, S5, and S6). The most probable unbinding forces to break FGF-2 – interactions 
are depicted in Figure 4D and these increased linearly with respect to the logarithm of the 
applied loading rates.  In contrast to physiological and alkaline conditions, acidic pH increased 
then stability as demonstrated by increased unbinding forces to liberate FGF-2 from the binary 
complex (Figure 4D black triangles). Supporting this finding, the koff value of the heparin – 
FGF-2 complex was reduced by 23 % at acidic pH in comparison to physiological and alkaline 
conditions (Table 3).  
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Discussion  
We detailed the interaction between FGF-2 and heparin at the single-molecular level using 
AFM-based pulling and force clamp experiments, including assessments at different pH as 
relevant for (patho-)physiological conditions. Our customized AFM system, employing an 
electromagnet with magnetic beads as actuators, has been previously shown to enable force 
spectroscopic measurements between biotin and streptavidin serving as a well-studied high 
affinity model receptor ligand system at high loading rates (103 to 303 pN/s).20  Low affinity 
interactions – characteristic of the FGF-2 – heparin complex as reported here – required a stable 
AFM setup with maximum resolution particularly when used at the low loading rate regime (101 
to 102 pN/s). . Our setup enabled sensitive biomolecular force measurements as the cantilever is 
operated away from stationary surfaces, allowing low actuation speeds and decrease of contact 
forces acting on the interacting biomolecules. We were therefore able to vary the loading rate 
with more than five-orders of magnitude (Figure 1C). Our applied magnetic bead actuation 
method was advantageous for the force clamp experiments, facilitating the stability of force 
levels applied to the FGF-2–heparin complex, without the need of active feedback as needed in 
conventional AFM systems. We demonstrated that the interaction between FGF-2 and heparin 
was specific (Figure 2A) and had slip bond characteristics (as the life time decreased with the 
clamping force; Figure 3D). Life-times of FGF-2–heparin complexes were short-lived with ~ 
0.41 s without (as extrapolated) and ~ 0.19 s in the presence of an tensile force (clamping force: 
172 pN), suggesting that cells exerting forces in the pN-range on the ECM may modulate FGF-2 
binding to the ECM. Through this mechanism the availability of bound pools for FGF-2 may 
indeed be controlled by surrounding cells with cells pulling at the ECM with increased forces as 
demonstrated during tissue remodeling25 driving FGF-2 release – a paracrine growth factor (GF) 
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being a potent regulator of cell growth and differentiation of primarily cells of mesodermal 
origin as required for tissue repair.  
Binding between FGF-2 and heparin is based on electrostatic (residues K135, Q134, N27, R120, 
K119, K129) interactions, hydrogen bonding and van der Waals forces26, resulting in strong 
enthalpic contributions during formation of the FGF-2–heparin complex. Our results – as 
analyzed by ITC - revealed that acidic pH reduced intermolecular interactions (ΔH), whereas the 
entropic contribution (TΔS) increased (Figure 4A–C; Table 2). For all conditions tested (acidic: 
pH 5.5, physiological: pH 7.4, alkaline: pH 8.5) the equilibrium dissociation constant KD and the 
overall free energy change (ΔG) remained constant. This reciprocal relationship between 
enthalpy and entropy, resulting in constant free energy levels of the interaction, is known as the 
enthalpy – entropy (H/S) compensation mechanism.27 We speculate that the release of hydrogen 
bonded and trapped water within the binding cavities of FGF-2 and heparin drove the entropy 
change at acidic conditions, an interaction, strongly impacted by pH. pH dependency of the FGF-
2 – heparin interaction was further detailed by biomolecular pulling AFM experiments (Figure 
4D). Recorded unbinding forces versus loading rates were indistinguishable at physiological and 
at basic pH-values. In contrast, acidic conditions resulted in a stabilized FGF-2– heparin 
complex as demonstrated by increased unbinding forces and an overall reduced koff value (Table 
3). These insights are in line with previous studies, detailing transport of FGF-2 within the 
pericellular space which did not follow simple diffusion pattern.28 This is due to the fact that HS 
are ubiquitous present and in concentrations greatly exceeding FGFs levels in tissues. We 
speculate that binding of FGF-2 to HS is favored at acidic conditions to form locally 
concentrated pools within the ECM (Figure 4E). These might contribute in gradient formation as 
needed to guide cells in angiogenesis or tissue development.29   
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In summary, the insights provided here point to an intriguing self-regulating mechanism based 
on the observation that (i) acidic pH increases heparin binding of FGF-2 while (ii) strain releases 
FGF-2 from heparin. Pathophysiological pH decrease as of traumatic ischemia (reducing tissue 
pH and reflecting process (i) of our experiments) favors FGF-2 binding, thereby replenishment 
the diseased tissue with this trophic growth factor and directing it from the interstitial space to 
the sites in need. Once tissue repair has advanced to a state that repairing cells exert strain to the 
ECM (reflecting process (ii) of our experiments), bound FGF-2 is released, thereby regulating 
cell growth and differentiation. Certainly, future work is necessary to extrapolate the effects of 
pH dependency and nanomechanics – as observed on the molecular level here – to another 
hierarchical level including cells, tissues and, organs in health and disease.   
Conclusion 
 
In summary, these data provide first nanomechanical insights into the FGF-2 at the molecular 
level with a modular AFM system designed for biomolecular experiments.  Unbinding events 
between FGF-2 and heparin were specific with life-times decreasing with tensile force on the 
bond. Solution pH modulated FGF-2 – heparin binding as demonstrated by enhanced rupture 
forces at acidic conditions compared to physiological pH with implications for storage and 
release coordination in the extracellular space. AFM with magnetic bead actuation as 
demonstrated for protein-ligand interactions here is a convenient tool and may be of general 
relevance to study intramolecular forces and kinetics at the level of individual molecules.  
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Material & Methods 
 
Materials 
Carbenicillin disodium, phenylmethanesulfonyl fluoride (PMSF), poly(propylene glycol) 
(Average Mn ~ 2,000 Da), N-Hydroxysulfosuccinimide sodium salt (Sulfo-NHS), N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and 2-(N-Morpholino)ethane 
sulfonic acid hydrate (MES hydrate), bovine serum albumin (BSA) and phosphate buffered 
saline (PBS) tablets were purchased from Sigma Aldrich (Schnelldorf, Germany). Micromer®-M 
PEG-NH2 beads (5 µm) were acquired from micromod Partikeltechnologie (Rostock, Germany). 
Enoxaparin sodium (low molecular weight heparin) was bought from Sanofi-Aventis (Clexane®, 
Frankfurt, Germany). Non-conductive Silicon Nitride MLCT-C type cantilever with nominal 
spring constant of 0.01 N/m–Veeco probes were from Bruker Cooperation (Karlsruhe, 
Germany). Silicon Nitride PNP-TR type cantilevers with nominal spring constant of 0.08 N/m 
were from Nanoworld (Neuchatel, Switzerland). All other chemicals used were at least of 
pharmaceutical grade and were purchased from Sigma-Aldrich (unless noted otherwise).  
Expression and purification of murine FGF-2 
Murine FGF-2 was subcloned and expressed as described before.30-31  Briefly, protein expression 
of the fusionprotein pHisTrx-FGF-2 was induced with 0.2 mM IPTG at OD600 = 0.6 and 
expression was performed at 30° C at 200 rpm. After 5h cells were harvested by centrifugation 
and were resuspended in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM PMSF, pH 7.5) 
and solubilized by sonification at 4° C. After centrifugation at 100,000 g for 1h at 4° C (L8-60M 
Ultracentrifuge, Beckman-Coulter, Brea, CA), the supernatant containing pHisTrx tagged FGF-2 
was purified by heparin-sepharose affinity chromatography using an FPLC system (Aekta 
Purifier, GE, Freiburg, Germany). After dialysis against PBS, supplemented with 1 mM DTT, 
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the fusionprotein pHisTrx-FGF-2 was cleaved by thrombin (GE, Freiburg, Germany) with a final 
concentration of 1U thrombin/mg fusionprotein at 4°C overnight. After stopping the reaction 
with 1 mM PMSF, murine FGF-2 was purified by heparin affinity chromatography. Storage of 
murine FGF-2 was in PBS supplemented with 3 mM DTT as anti-oxidative agent at -80°C. FGF-
2 concentration was determined by UV-absorbance at λ= 280 nm, using an extinction coefficient 
of 16766 ± 239 (E0.1% = 0.964) as described.32 
Decoration of magnetic beads with heparin via EDC/Sulfo-NHS coupling 
Magnetic and surface functionalized PEG-NH2 beads were used to reduce non-specific 
interactions and to prevent aggregation of the beads during the experiments. 1 mg Enoxaparin 
was added to the activation buffer (0.1 M MES, 0.5 M NaCl, pH 6.0) containing a tenfold molar 
excess of EDC and 30 mM Sulfo-NHS as described.30 The mixture was vortexed and incubated 
for 15 min at room temperature. After activation, the solution was transferred into concentrated 
phosphate buffer, containing 0.2 mg PEG-NH2 beads, to raise the pH above neutral. For at least 2 
h the suspension was agitated with a Thermomixer comfort (Eppendorf, Hamburg, Germany) to 
maintain the particles dispersed in solution. After the coupling reaction the beads were washed 
several times using PBS with increased ionic strength (0.5 M NaCl) and Milli-Q water.  
 
Physioadsorption of FGF-2 onto cantilevers 
MLCT-C and PNP-TR cantilevers were incubated with a FGF-2 droplet with a final 
concentration of 112.5 µg/mL in PBS for 30 min at room temperature, prior to use. This 
concentration was chosen to observe probabilities of unbinding events of about 30 %. The spring 
constant values of all the cantilevers used during the experiments were calibrated using thermal 
noise method. 
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Single molecule pulling experiments with magnetic bead actuation 
Prior to injection of heparin decorated magnetic beads between the cantilever and a cover slip 
into the magnetic33 actuation based AFM system, the cover slip surface was blocked with 50 µL 
BSA  with a final  concentration of 40 µg/mL for 30 minutes in order to avoid non-specific 
adhesions between the functionalized MLCT-C type FGF-2 cantilever and the cover glass. After 
washing away the excess BSA, 100 µL-droplet of PBS was placed into which the heparin-
decorated beads were carefully injected using a micropipette. The concentration of heparin 
molecules immobilized onto the bead was adjusted for probabilities of unbinding events at about 
30 %. Several hundreds of force curves were obtained at different loading rates, ranging from 
101 to 104 pN/s by using the magnetic micro particles as actuators. Values of loading rates on 
individual force curves were recorded before the specific unbinding events and to avoid the 
additional effect of PEG-NH2 polymer on the magnetic bead surface. Three different sets of 
control experiments were performed to test the specificity of the measured data. The first 
unbinding control experiment was performed in the presence of 10-fold excess of NaCl in the 
buffer. The second control experiment was performed after keeping the FGF-2 coated cantilevers 
inside the heparin solution overnight to saturate the FGF-2 molecules on the cantilever with 
heparin. In the last control experiment, binding of the FGF-2 coated cantilevers was tested 
against unmodified blank magnetic beads. Detailed information about the instrument setup and 
procedures of biomolecular pulling measurements by using the magnetic actuation method are 
described elsewhere.19,20  
Single molecule force clamp experiments with magnetic bead actuation 
In the force clamp experiments the custom build AFM system was used with electromagnetic 
actuation. The method of actuating magnetic particles against a stationary cantilever allows for 
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the application of constant force on biomolecules to perform force clamp experiments without 
any active feedback.20 The magnetic field and gradient applied on the magnetic particle 
determine the force, which can be kept constant by driving the electromagnet with a constant 
current signal. MLCT type cantilevers and the beads were prepared following the same 
procedures as described for force pulling experiments. The piezoactuator of the cantilever was 
used to grab magnetic beads and then constant force was applied on the beads until an unbinding 
event was observed. The duration of time between the instance when the force was applied and 
the instance of unbinding, i.e. life-time, was recorded for each condition. 
The Bell-Evans model was used for the calculation of the kinetic rate of dissociation (koff) and of 
the barrier width (Δx).34 (koff(F)) values were determined following the relationships: 
𝑘!""(𝐹) = 𝑘!""exp !!!!
Δ!                                                     (1) 
𝐹 = !!!!! ln !!!!! !!∙ !!""                                                     (2) 
, where kB is the Boltzmann constant and T is the temperature.   
Single molecule pulling experiments with piezo actuation 
In addition to the method of magnetic bead actuation, single molecule pulling experiments were 
also performed using the conventional method of piezo actuation. Two sets of pulling 
experiments were performed using both the custom-built AFM setup and a commercially 
available AFM system (Dimension Edge, Bruker, Karlsruhe, Germany). PNP-TR type 
cantilevers were used for these experiments and the cantilevers were incubated in FGF-2 as 
described before. These cantilevers were tested against cover slips, which were incubated with 
heparin with a concentration of 20 µg/mL at room temperature. Then, the excess heparin was 
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washed away and the cover slips were later incubated for 30 minutes with 50 µL of BSA with a 
concentration of 40 µg/mL, which was washed away after incubation to avoid non-specific 
interactions. Finally, the experiments were performed in a 100 µL-droplet of PBS. During the 
experiments, the piezo actuators of the AFM setups were actuated using triangular waves at 
various speeds to induce different loading rates ranging from 103 to 107 pN/s. 
 
Isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) experiments were performed on a MicroCal–iTC 200 
system (GE healthcare, Munich, Germany). 150 µM heparin dissolved in PBS supplemented 
with 0.5 mM DTT was titrated in 2 µL steps to 30 µM of FGF-2 in PBS containing 0.5 mM DTT 
in 4.0 s intervals at different pH values (5.5, 7.4, and 8.5). A constant temperature of 20° C and a 
stirring speed of 400 rpm were maintained throughout the experiment. A total number of 19 
injections were performed. Heats determined in the absence of heparin were subtracted from the 
titration data before curve fitting. Additionally, an initial 0.4 µL injection was discarded from 
each dataset to remove the effect of titrant diffusion across the syringe tip during the 
equilibration process. After the integration of the injection peaks the area (heat exchange per 
injection) was plotted against the molar ratio of heparin/mFGF-2 assuming a sigmoidal fitting 
model using Origin® scientific plotting software to calculate the binding enthalpy ΔH and the 
dissociation constant KD. The free energy change (ΔG) was calculated from the relationship: 
  ΔG = RTln KD       (3) 
with R as the universal molar gas constant (1.99 cal *mol-1K-1) and T as the absolute 
temperature. The entropic term (TΔS) to the free energy was determined following the 
relationship: 
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TΔS = ΔH  ̶  ΔG      (4) 
Statistics  
Data were analyzed to perform one-way ANOVA using the software package MatLab 
(MathWorks,  Natick, Massachusetts, USA). Results were considered statistically significant at p 
≤ 0.05 (*) and results are displayed as mean with standard deviation (SD) unless specified 
otherwise.   
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Figure legends 
 
Figure 1: (A) Crystal structure of FGF-2 (grey) interacting with a heparin tetra fragment (blue 
colored by element). pdb file = 1BFB.  (B) Schematic representation of the dually actuated AFM 
setup, using piezo and/or magnetic actuation method. 
Figure 2: (A) Probability of unbinding force for heparin and FGF-2 single molecular interaction 
and control experiments using magnetic bead actuation method, collective data for the whole 
range of loading rates from 101 to 104 pN/s are used. (B) a sample force curve with 70 pN/s 
loading rate showing 50 pN unbinding force, for the corresponding event from the biomolecular 
interaction between the heparin labeled magnetic bead and FGF2 functionalized cantilever, (C) 
Unbinding force versus loading rates graph for heparin and FGF2 pulling experiments using 
magnetic bead actuation method (black circles), piezo actuation method on custom AFM setup 
(red stars), and on a commercial AFM system (Dimension Edge, Bruker) (blue triangulars). R2 
values in linear regression for both energy barriers (low and high loading rates) were 0.96 and 
0.91, respectively. 
Figure 3: (A) A representative force clamp curve with 60 pN clamping force showing 600 ms 
life-time before unbinding. (B) Cumulative probability density graph of life-times under 19.6 pN 
(black), 38.9 pN (blue) and 61.6 pN (red) with their corresponding exponential fits. (C) Density 
histogram versus life time with exponential fitting. (D) Unbinding rate (life time-1) versus 
clamping force and linear fitting.  
Figure 4: Isothermal titration calorimetry curves between heparin and FGF-2 in PBS at a pH of 
(A) 5.5, (B) 7.4, and (C) 8.5, respectively. (D) The most probable unbinding force versus loading 
rates graph for heparin and FGF-2 interactions. Each labels represent s the experiments which 
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are carried out in different pH environments i.e. pH 5.5 (black triangles), pH 7.4 (red circles) and 
pH 8.5 (blue triangles) using magnetic actuation method.  (E) Proposed pH dependency model 
for FGF-2 heparin interaction. 
 
Table: 1:  Bell’s parameters of heparin FGF-2 interaction at different loading rates regimes.  
Table: 2:  Thermodynamic parameters of heparin –FGF-2 interaction as analyzed by ITC.  
Table: 3:  Bell’s parameters of heparin FGF-2 interaction at different pH values. 
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Table 1: 
 Range of loading rate 
[pN] 
Barrier width, Δx  
[nm] 
Kinetic rate of dissociation, koff 
[s-1] 
Regime 1 101 – 106 0.4244 0.6198 
Regime 2 106 – 107 0.0231 2774 
 
Table 2: 
 T 
[K] 
# n KD 
[nM] 
ΔH 
[kcal/mol] 
ΔG 
[kcal/mol] 
TΔS 
[kcal/mol] 
pH 5.5 293.15 3 3.41±0.29 221±20 -12.7±0.5 -8.9±0.05 -3.8±0.46 
pH 7.4 293.15 4 2.97±0.11 232±5 -15.4±0.5 -8.9±0.01 -6.5±0.48 
pH 8.5 293.15 5 3.29±0.42 293±32 -20.2±1.1 -8.8±0.07 -11.4±1.1 
 
Table 3: 
pH values Range of loading rate 
[pN] 
Barrier width, Δx  
[nm] 
Kinetic rate of dissociation, koff 
[s-1] 
pH 5.5 101 - 104 0.3293 0.5996 
pH 7.4 101 - 104 0.4191 0.7836 
pH 8.5 101 - 104 0.4407 0.7661 
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